Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells

[1]  J. Ahnfelt-Rønne,et al.  The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates , 2017, Molecular metabolism.

[2]  Kyle J. Gaulton,et al.  Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci , 2017, bioRxiv.

[3]  Giovanni Malerba,et al.  Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes , 2017, Nature Genetics.

[4]  Stephen Burgess,et al.  Consequences of natural perturbations in the human plasma proteome , 2017, bioRxiv.

[5]  A. Gloyn,et al.  Human genetics as a model for target validation: finding new therapies for diabetes , 2017, Diabetologia.

[6]  N. Webster,et al.  Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion , 2017, Cell and Tissue Research.

[7]  S. Mahata,et al.  Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity , 2017, Front. Endocrinol..

[8]  Stephen C. J. Parker,et al.  The genetic architecture of type 2 diabetes , 2016, Nature.

[9]  P. MacDonald,et al.  Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore. , 2016, Endocrinology.

[10]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[11]  Mark I. McCarthy,et al.  Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors , 2015, PLoS genetics.

[12]  Eric Banks,et al.  Tools and best practices for data processing in allelic expression analysis , 2015, Genome Biology.

[13]  Jonathan K. Pritchard,et al.  WASP: allele-specific software for robust molecular quantitative trait locus discovery , 2015, Nature Methods.

[14]  P. Ratcliffe,et al.  Striking Oxygen Sensitivity of the Peptidylglycine α-Amidating Monooxygenase (PAM) in Neuroendocrine Cells* , 2015, The Journal of Biological Chemistry.

[15]  S. Lenzen,et al.  Physiological characterization of the human EndoC-βH1 β-cell line. , 2015, Biochemical and biophysical research communications.

[16]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[17]  M. McCarthy,et al.  Human islet function following 20 years of cryogenic biobanking , 2015, Diabetologia.

[18]  Dale L. Greiner,et al.  Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets , 2015, Diabetes.

[19]  R. Scharfmann,et al.  Characterization of Stimulus-Secretion Coupling in the Human Pancreatic EndoC-βH1 Beta Cell Line , 2015, PloS one.

[20]  P. Rorsman,et al.  RFX6 regulates insulin secretion by modulating Ca2+ homeostasis in human β cells. , 2014, Cell reports.

[21]  C. Donaldson,et al.  The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression , 2014, BMC Genomics.

[22]  Inês Barroso,et al.  Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity , 2014, Diabetes.

[23]  Kari Stefansson,et al.  Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes , 2014, Nature Genetics.

[24]  Halit Ongen,et al.  Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome , 2013, Genome research.

[25]  Patrik Rorsman,et al.  Regulation of insulin secretion in human pancreatic islets. , 2013, Annual review of physiology.

[26]  Christian Fuchsberger,et al.  Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion , 2012, Nature Genetics.

[27]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[28]  S. Cross,et al.  Collagenase does Not Persist in Human Islets following Isolation , 2012, Cell transplantation.

[29]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[30]  Ayyalusamy Ramamoorthy,et al.  Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. , 2011, Biochimica et biophysica acta.

[31]  R. Scharfmann,et al.  A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. , 2011, The Journal of clinical investigation.

[32]  Y. Loh,et al.  The extended granin family: structure, function, and biomedical implications. , 2011, Endocrine reviews.

[33]  Y. Loh,et al.  Serpinin: a novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells. , 2011, Molecular endocrinology.

[34]  James D. Johnson,et al.  Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors , 2011, Diabetologia.

[35]  P. Rorsman,et al.  Defective Secretion of Islet Hormones in Chromogranin-B Deficient Mice , 2010, PloS one.

[36]  K. Helle,et al.  The endocrine role for chromogranin A: A prohormone for peptides with regulatory properties , 2007, Cellular and Molecular Life Sciences.

[37]  N. Schork,et al.  Biogenesis of the secretory granule: chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation. , 2007, Biochemistry.

[38]  R. Mains,et al.  Role for an Essential Tyrosine in Peptide Amidation* , 2006, Journal of Biological Chemistry.

[39]  Y. Loh,et al.  Protease nexin-1 promotes secretory granule biogenesis by preventing granule protein degradation. , 2005, Molecular biology of the cell.

[40]  S. Oyama,et al.  How C-terminal carboxyamidation alters the biological activity of peptides from the venom of the eumenine solitary wasp. , 2004, Biochemistry.

[41]  D. Merkler,et al.  An enzyme-coupled assay for glyoxylic acid. , 2003, Analytical biochemistry.

[42]  Michael B Wheeler,et al.  The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. , 2002, Diabetes.

[43]  M. A. Burrell,et al.  Immunocytochemical Finding of the Amidating Enzymes in Mouse Pancreatic A-, B-, and D-cells , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  A. Mor,et al.  Structural consequences of carboxyamidation of dermaseptin S3. , 2002, Biochemistry.

[45]  Y. Loh,et al.  Chromogranin A, an “On/Off” Switch Controlling Dense-Core Secretory Granule Biogenesis , 2001, Cell.

[46]  The International HapMap Consortium,et al.  A physical map of the human genome , 2001 .

[47]  R. Mains,et al.  Cell Type-Specific Metabolism of Peptidylglycineα -Amidating Monooxygenase in Anterior Pituitary. , 2000, Endocrinology.

[48]  A. Ichiyama,et al.  A spectrophotometric method for the determination of glycolate in urine and plasma with glycolate oxidase. , 2000, Journal of biochemistry.

[49]  M. Whitelaw,et al.  Multiple Roles of Ligand in Transforming the Dioxin Receptor to an Active Basic Helix-Loop-Helix/PAS Transcription Factor Complex with the Nuclear Protein Arnt , 1999, Molecular and Cellular Biology.

[50]  J. Holst,et al.  Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans , 1998, Regulatory Peptides.

[51]  R. Mains,et al.  Localization of integral membrane peptidylglycine alpha-amidating monooxygenase in neuroendocrine cells. , 1997, Journal of cell science.

[52]  R. Mains,et al.  Identification of Routing Determinants in the Cytosolic Domain of a Secretory Granule-associated Integral Membrane Protein* , 1996, The Journal of Biological Chemistry.

[53]  E. Neher,et al.  Protein Kinase C Enhances Exocytosis from Chromaffin Cells by Increasing the Size of the Readily Releasable Pool of Secretory Granules , 1996, Neuron.

[54]  G. Kicska,et al.  Secretory Granule Content Proteins and the Luminal Domains of Granule Membrane Proteins Aggregate in Vitro at Mildly Acidic pH (*) , 1996, The Journal of Biological Chemistry.

[55]  D. Merkler.  C‐Terminal Amidated Peptides: Production by the in vitro Enzymic Amidation of Glycine‐Extended Peptides and the Importance of the Amide to Bioactivity , 1994 .

[56]  D. Merkler,et al.  C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. , 1994, Enzyme and microbial technology.

[57]  C. Osmond,et al.  Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[58]  S. Yoo,et al.  Dimerization and tetramerization properties of the C-terminal region of chromogranin A: a thermodynamic analysis. , 1993, Biochemistry.

[59]  R. Mains,et al.  Peptidylglycine α‐amidating monooxygenase: A multifunctional protein with catalytic, processing, and routing domains , 1993, Protein science : a publication of the Protein Society.

[60]  B. Eipper,et al.  Neurosecretory Vesicles Contain Soluble and Membrane‐Associated Monofunctional and Bifunctional Peptidylglycine α‐Amidating Monooxygenase Proteins , 1993, Journal of Neurochemistry.

[61]  J. Polak,et al.  Immunocytochemical localization of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in human endocrine pancreas. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[62]  R. Mains,et al.  Expression of a peptide processing enzyme in cultured cells: truncation mutants reveal a routing domain. , 1992, Molecular endocrinology.

[63]  R. Mains,et al.  Alternative splicing and endoproteolytic processing generate tissue-specific forms of pituitary peptidylglycine alpha-amidating monooxygenase (PAM). , 1992, The Journal of biological chemistry.

[64]  S. Yoo,et al.  Ca2(+)-induced conformational change and aggregation of chromogranin A. , 1990, The Journal of biological chemistry.

[65]  A. Katopodis,et al.  Novel substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase. , 1990, Biochemistry.

[66]  An Zhou,et al.  Evidence for presence of peptide α-amidating activity in pancreatic islets from newborn rats , 1990 .

[67]  P. Giraud,et al.  Ontogenetic expression of peptidyl-glycine α-amidating monooxygenase mRNA in the rat pancreas , 1989 .

[68]  R. Scharfmann,et al.  Persistence of peptidylglycine alpha-amidating monooxygenase activity and elevated thyrotropin-releasing hormone concentrations in fetal rat islets in culture. , 1988, Endocrinology.